Get the Stockscreener App
2.85
0.00%
0.00
Qualigen Therapeutics Inc stock is traded at $2.85, with a volume of 158.81K.
It is up +0.00% in the last 24 hours and down -45.51% over the past month.
Qualigen Therapeutics Inc is an early-clinical-stage therapeutics company focused on developing treatments for adult and pediatric cancer. The company's business consists of one early-clinical-stage therapeutic program (QN-302) and one preclinical therapeutic program. The company's program, QN-302, is an investigational small-molecule G-quadruplexes (G4)-selective transcription inhibitor with binding affinity to G4s prevalent in cancer cells.
See More
Previous Close:
$2.85
Open:
$2.79
24h Volume:
158.81K
Relative Volume:
0.07
Market Cap:
$4.83M
Revenue:
$4.79M
Net Income/Loss:
$-13.42M
P/E Ratio:
-1.0714
EPS:
-2.66
Net Cash Flow:
$-10.30M
1W Performance:
-4.04%
1M Performance:
-45.51%
6M Performance:
-18.57%
1Y Performance:
-42.07%
1-Day Range:
$2.79
$2.92
1-Week Range:
$2.6601
$3.36
52-Week Range:
$1.61
$8.81
Qualigen Therapeutics Inc Stock (QLGN) Company Profile
Name
Qualigen Therapeutics Inc
Sector
Industry
Phone
(760) 918-9165
Address
2042 CORTE DEL NOGAL, CALIFORNIA
Compare QLGN with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
QLGN
Qualigen Therapeutics Inc
|
2.85 | 5.79M | 4.79M | -13.42M | -10.30M | -2.66 |
|
VRTX
Vertex Pharmaceuticals Inc
|
424.52 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
642.42 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
431.79 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
822.21 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
184.05 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Qualigen Therapeutics Inc Stock (QLGN) Latest News
Can Qualigen Therapeutics Inc. (7R90) stock retain market dominance2025 AllTime Highs & Weekly High Return Opportunities - newser.com
Will Qualigen Therapeutics Inc. rebound enough to break evenQuarterly Earnings Report & Consistent Profit Focused Trading Strategies - newser.com
Why Qualigen Therapeutics Inc. (7R90) stock could be next leader2025 Momentum Check & Risk Controlled Stock Pick Alerts - newser.com
Using fundamentals and technicals on Qualigen Therapeutics Inc.Exit Point & High Accuracy Buy Signal Tips - newser.com
Using flow based indicators on Qualigen Therapeutics Inc.Bull Run & Stock Timing and Entry Methods - newser.com
Is Qualigen Therapeutics Inc. (7R90) stock a top pick for value investorsExit Point & Pattern Based Trade Signal System - newser.com
How Qualigen Therapeutics Inc. (7R90) stock trades in high volatilityWeekly Profit Analysis & Reliable Volume Spike Trade Alerts - newser.com
Why Qualigen Therapeutics Inc. (7R90) stock attracts HNW investors2025 Investor Takeaways & Weekly High Momentum Picks - newser.com
Is Qualigen Therapeutics Inc. stock a safe investment in uncertain marketsJuly 2025 Big Picture & Weekly Top Gainers Alerts - newser.com
Why Qualigen Therapeutics Inc. (7R90) stock is a strong buy callEntry Point & AI Powered Buy/Sell Recommendations - newser.com
What insider purchases suggest about Qualigen Therapeutics Inc. (7R90) stockWeekly Market Outlook & Verified Swing Trading Watchlists - newser.com
Why Qualigen Therapeutics Inc. stock is trending among retail traders2025 Risk Factors & Expert Approved Momentum Ideas - newser.com
What institutional flow reveals about Qualigen Therapeutics Inc.Trade Volume Report & Technical Entry and Exit Tips - newser.com
Automated trading signals detected on Qualigen Therapeutics Inc.Weekly Trade Analysis & Proven Capital Preservation Tips - newser.com
Is Qualigen Therapeutics Inc. stock a safe buy before earnings2025 Trading Volume Trends & Fast Moving Market Watchlists - newser.com
Published on: 2025-11-02 21:07:13 - newser.com
Faraday Future Founder and Co-CEO YT Jia Shares Weekly Investor Update: FF Appoints Chris Nixon Cox as Global Strategic Advisor to Accelerate Global Expansion of “EAI + Crypto” Strategy - GlobeNewswire Inc.
Can Qualigen Therapeutics Inc. (7R90) stock sustain revenue momentum2025 Sector Review & Safe Entry Zone Tips - newser.com
Is Qualigen Therapeutics Inc. a candidate for recovery playStop Loss & High Accuracy Swing Entry Alerts - newser.com
Can swing trading help recover from Qualigen Therapeutics Inc. lossesJuly 2025 Outlook & Weekly Setup with High ROI Potential - newser.com
Published on: 2025-11-02 07:20:20 - newser.com
Will a bounce in Qualigen Therapeutics Inc. offer an exitQuarterly Portfolio Summary & Weekly High Potential Alerts - newser.com
How Qualigen Therapeutics Inc. stock compares to industry benchmarks2025 Technical Overview & Advanced Technical Analysis Signals - newser.com
Published on: 2025-11-02 01:49:21 - newser.com
Exit strategy if you’re trapped in Qualigen Therapeutics Inc.2025 AllTime Highs & Accurate Trade Setup Notifications - newser.com
What recovery options are there for Qualigen Therapeutics Inc.July 2025 WrapUp & Reliable Entry Point Trade Alerts - newser.com
Is Qualigen Therapeutics Inc. stock ready for a breakoutBond Market & Weekly Momentum Stock Picks - newser.com
Why hedge funds are buying Qualigen Therapeutics Inc. stockEarnings Overview Summary & AI Powered Market Trend Analysis - newser.com
Qualigen Therapeutics Inc Stock (QLGN) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.27%
0.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):